newsfilter
← Latest News
GlobeNewswire·

Kineta to Participate in Upcoming Investor Conferences

KA

SEATTLE, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (NASDAQ:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance,